ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $964,000 | +17.3% | 661,729 | +14.1% | 0.00% | 0.0% |
| Q4 2016 | $822,000 | -5.6% | 580,132 | +16.4% | 0.00% | 0.0% |
| Q3 2016 | $871,000 | -21.2% | 498,453 | -23.0% | 0.00% | 0.0% |
| Q2 2016 | $1,105,000 | +133.1% | 647,161 | +167.2% | 0.00% | – |
| Q1 2016 | $474,000 | +53.9% | 242,226 | +47.7% | 0.00% | – |
| Q4 2015 | $308,000 | -63.2% | 163,958 | -62.8% | 0.00% | -100.0% |
| Q3 2015 | $838,000 | -12.5% | 440,300 | +112.7% | 0.00% | 0.0% |
| Q2 2015 | $958,000 | +71.4% | 206,987 | +60.9% | 0.00% | – |
| Q1 2015 | $559,000 | +53.6% | 128,615 | +21.7% | 0.00% | – |
| Q4 2014 | $364,000 | -85.7% | 105,658 | -82.6% | 0.00% | -100.0% |
| Q3 2014 | $2,539,000 | -33.0% | 606,408 | -6.4% | 0.00% | -33.3% |
| Q2 2014 | $3,792,000 | -8.4% | 647,718 | -1.7% | 0.00% | 0.0% |
| Q1 2014 | $4,138,000 | -32.3% | 658,893 | -36.9% | 0.00% | -25.0% |
| Q4 2013 | $6,110,000 | +9.3% | 1,044,621 | -1.6% | 0.00% | 0.0% |
| Q3 2013 | $5,589,000 | – | 1,061,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |